Palmitoylation-related ACSM3 suppresses ovarian cancer progression via interacting with HSPD1 and regulating lipid metabolism
Cellular Oncology · 30.10.2026
DOI: 10.1007/s13402-026-01318-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 30.10.2026. Verfasst von Qin Ling und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ling, Q., Xu, H., Chen, Y., Yang, S., Tan, H., Zhang, Z., Sun, T., Kang, J., Lai, H., Chen, J., Wu, L., & Yang, G. (2026). Palmitoylation-related ACSM3 suppresses ovarian cancer progression via interacting with HSPD1 and regulating lipid metabolism. Cellular Oncology. https://doi.org/10.1007/s13402-026-01318-y
Vancouver
Ling Q, Xu H, Chen Y, Yang S, Tan H, Zhang Z, et al. Palmitoylation-related ACSM3 suppresses ovarian cancer progression via interacting with HSPD1 and regulating lipid metabolism. Cellular Oncology. 2026. doi:10.1007/s13402-026-01318-y
BibTeX
@article{Ling2026,
author = {Ling, Qin and Xu, Huishan and Chen, Yuying and Yang, Siqi and Tan, Hao and Zhang, Zuwei and Sun, Tingting and Kang, Jihui and Lai, Huiling and Chen, Jinglan and Wu, Linxiang and Yang, Guofen},
title = {Palmitoylation-related ACSM3 suppresses ovarian cancer progression via interacting with HSPD1 and regulating lipid metabolism},
journal = {Cellular Oncology},
year = {2026},
doi = {10.1007/s13402-026-01318-y}
}
EUVIMED